Juan C. Jaen, SVP, Drug Discovery & CSO at ChemoCentryx, Inc. (CCXI), sold 22,201 shares at $11.89 ($264K) on 2013-02-21, disclosed to the SEC on 2013-02-21.
Scheduled sale ($264k) by SVP, Drug Discovery & CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.85 | 700 | $8K | 3.1% |
| 2 | $11.86 | 6,800 | $81K | 30.5% |
| 3 | $11.95 | 8,000 | $96K | 36.2% |
| 4 | $11.90 | 5,601 | $67K | 25.2% |
| 5 | $11.89 | 1,100 | $13K | 4.9% |
| Total | $11.90 avg | 22,201 |
| $264K |
| 100% |
| Filing → |
| RCUS | SELL | 2026-01-07 | $681K | — | Filing → |
| RCUS | SELL | 2025-12-18 | $688K | — | Filing → |
| RCUS | SELL | 2025-12-05 | $4.1M | — | Filing → |